Information Society Services
Turkey's first domestic plasma production facilities. Turkey's first domestic plasma production facilities.

Turkey's first domestic plasma production facilities.

It produced in a few centers in the world, if not the production of blood products in Turkey so far, will be produced by maxicells in Turkey.

DETAILS
Turkey's most important biological drug production investment. Turkey's most important biological drug production investment.

Turkey's most important biological drug production investment.

Continuing its investments in biological medicine production, Maxicells is becoming one of the most important companies in the sector.

DETAILS
Our priority is to improve human health. Our priority is to improve human health.

Our priority is to improve human health.

As Maxicells, we carry out our activities within the framework of the mission we have acquired in line with the value we give to people.

DETAILS

News

Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Turkey will save 15 billion Turkish Lira by domestically producing the plasma obtained from blood and blood products which are otherwise considered among the major import items.

DETAILS
Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Following the announcement stipulating that domestic plasma products may be produced in Turkey, 18 companies aspired to this production activity.

DETAILS
Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

The countdown has been initiated for the production of domestic plasma in collaboration with the Ministry of Health, The Social Security Institution (SSI) and the Turkish Red Crescent.

DETAILS
Maxicells Will Produce 4 Plasma Products In Turkey Within The Scope Of The Project

Maxicells Will Produce 4 Plasma Products In Turkey Within The Scope Of The Project

Turkey will save 15 billion Turkish Lira by domestically producing the plasma obtained from blood and blood products which are otherwise considered among the major import items.

DETAILS
Maxicells Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Maxicells Maxicells will contribute 15 billion Turkish Lira to the Government with Domestic Plasma

Turkey will save 15 billion Turkish Lira by domestically producing the plasma obtained from blood and blood products which are otherwise considered among the major import items.

DETAILS
About Maxicells

About Maxicells

In accordance with the government's goal of localization in health and medicine; Maxicells initiated its investments in 2017, aiming to become the leading biological drug provider and manufacturer both in Turkey and throughout the world. Maxicells has set out to produce specific blood products that have already been manufactured by a few centers in the world, however not yet been produced in Turkey. Maxicells, which has already prepared its investment plans to build the very first plant of Turkey to produce specific blood products, has undertaken the procurement of  4 main plasma products (factor 8, factor 9, immunoglobulin and albumin) as finished products within the 5-year period until the beginning of domestic production.

Do You Have Any Questions?

You can request further information about our products by contacting our team members. You may also submit us additional information by filling out our Adverse Effect Reporting Form.

ADVERSE EFFECT REPORTING FORM
Contact Form